Reilly, Madeleine
Benilova, Iryna
Khalili-Shirazi, Azadeh
Schmidt, Christian
Ahmed, Parvin
Yip, Daniel
Jat, Parmjit S.
Collinge, John
Funding for this research was provided by:
Medical Research Council (MC_UU_00024/2, MC_UU_00024/7)
Article History
Received: 1 February 2022
Accepted: 9 May 2022
First Online: 9 June 2022
Competing interests
: J.C. is a Director and shareholder of D-Gen Limited, an academic spinout company in the field of prion disease diagnostics and therapeutics which supplied the ICSM18 antibody used in the study. All other authors declare no competing financial interest.